Live Accenture Plc Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow IR-Med, Inc.

Get SEC filing alerts via email and in your feed for IR-Med, Inc.

IRME

IR-Med, Inc.

About IR-Med, Inc.

IR-Med, Inc. develops non-invasive point-of-care diagnostic devices utilizing infrared spectroscopy and AI to assess and monitor conditions like pressure injuries and diabetic foot ulcers. Its products, PressureSafe and DiaSafe, target healthcare providers, hospitals, and homecare markets worldwide. The company's innovative technology aims to improve early diagnosis, reduce healthcare costs, and address unmet medical needs through portable, AI-driven solutions.
This description was generated via AI from an annual report. Updated 9 months ago.

Latest SEC Filings from IR-Med, Inc.

1
1
IR-Med, Inc. IR-Med Reports Increased Losses and Ongoing Financial Challenges for Six-Month Period Ending June 30, 2025

Via official filing (AI summary) | 10 months ago | 0 comments

2
1
IR-Med, Inc. IR-Med Reports $253.7 Million Operating Loss in Q1 2025, Prepares for Product Launch

Via official filing (AI summary) | about 1 year ago | 0 comments

3
1
IR-Med, Inc. IR-Med Reports Reduced Operating Losses and Progress on PressureSafe™ Device

Via official filing (AI summary) | about 1 year ago | 0 comments

4
1
IR-Med, Inc. IR-Med Reports Improved Financials, Loss Reduction, and Plans for Additional Financing

Via official filing (AI summary) | over 1 year ago | 0 comments